Development and evaluation of a health-promoting meal for late middle-aged women in menopause

ISRCTN ISRCTN11827482
DOI https://doi.org/10.1186/ISRCTN11827482
Secondary identifying numbers EUMC 2020-02-047
Submission date
12/10/2025
Registration date
16/10/2025
Last edited
15/10/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Menopause is a critical transition in a woman’s life, characterized by hormonal changes such as increased follicle-stimulating hormone (FSH) and decreased estradiol (E2). These changes often lead to menopausal symptoms, including sleep disturbances and depressive mood, which substantially affect health and quality of life in late middle-aged women. Moreover, this period is associated with an increased risk of chronic diseases, highlighting the importance of appropriate health management and promotion of well-being.
Previous studies have shown that a balanced dietary pattern, with adequate consumption of diverse foods, has positive effects on alleviating menopausal symptoms and preventing chronic diseases in late middle-aged women. In particular, sufficient intake of calcium, omega-3 fatty acids, dietary fiber, and isoflavones has been reported to be closely linked with reducing chronic disease risk in this population.
Therefore, the aim of this study is to develop and implement a health-promoting meal plan enriched with these key nutrients (calcium, omega-3 fatty acids, dietary fiber, and isoflavones) and to evaluate its effects on improving health outcomes among late middle-aged women.

Who can participate?
Women aged between 50 and 65 years.

What does the study involve?
All participants were provided with a health-promoting meal plan for 8 weeks and, their nutritional intake was monitored during the intervention period. Menopausal symptoms, sleep quality, body measurements, blood parameters, continuous glucose monitoring, and plasma and urine metabolomics were assessed before and after the intervention.

What are the possible benefits and risks of participating?
Participants may have benefited from following a meal plan developed to promote health and improve metabolic outcomes. No major risks were reported. Minor risks included slight discomfort or inconvenience from blood sample collection.

Where is the study run from?
Ewha Clinical Trial Center, Ewha Womans University Mokdong Hospital (South Korea)

When is the study starting and how long is it expected to run for?
January 2019 to September 2021

Who is funding the study?
Ewha Womans University and Dr. Kitchen Co., Ltd. (South Korea)

Who is the main contact?
Dr. Yangha Kim
yhmoon@ewha.ac.kr

Contact information

Prof Yangha Kim
Principal investigator

Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu
Seoul
03760
Korea, South

ORCiD logoORCID ID 0000-0002-7280-7597
Phone +82 2-3277-3101
Email yhmoon@ewha.ac.kr
Prof Eunhee Ha
Principal investigator

Department of Environmental Medicine, Ewha Womans University College of Medicine, 25, Magokdong-ro 2-gil, Gangseo-gu
Seoul
07804
Korea, South

ORCiD logoORCID ID 0000-0002-4224-3858
Phone +82 2-6986-6013
Email eunheeha@ewha.ac.kr
Prof Yoon Jung Park
Public, Scientific, Principal investigator

Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu
Seoul
03760
Korea, South

ORCiD logoORCID ID 0000-0001-6999-4996
Phone +82 2-3277-6533
Email park.yoonjung@ewha.ac.kr

Study information

Study designSingle-arm pre-post interventional study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Home, Hospital
Study typeTreatment, Efficacy
Participant information sheet 48172 Participant information sheet.pdf
Scientific titleImpact of a tailored meal plan on metabolic health in late middle-aged women: an 8-week pre-post intervention trial
Study objectivesTo investigate the effect of a health-promoting meal plan on metabolic health outcomes in late middle-aged postmenopausal women.
Ethics approval(s)

Approved 05/10/2020, Ewha Womans University Mokdong Hospital (1071, Anyangcheon-ro, Yangcheon-gu, Seoul, Republic of Korea, Seoul, 07985, Korea, South; +82 2-2650-2019; Irb-mok@eumc.ac.kr), ref: EUMC 2020-02-047

Health condition(s) or problem(s) studiedLate middle-aged postmenopausal women
InterventionSixty-one participants underwent the intervention and were provided with a health-promoting meal plan for 8 weeks.
The meal plan was developed by registered dietitians to enrich four major nutrients (calcium, omega-3, fiber, and isoflavone) that showed insufficient intake in late middle-aged women. Meals were supplied as two meals per day (lunch, dinner) and one snack, designed to provide approximately 80% of the estimated daily energy requirement. The meals were provided in the form of meal kits with accompanying recipe cards. Participants were instructed to prepare and consume meals at regular times according to their individual eating schedules, with a simple breakfast being recommended.
Participants were assessed before and after intervention for menopausal symptoms, sleep quality, anthropometric indices, blood parameters, continuous glucose monitoring, and plasma and urine metabolomics.
Intervention typeOther
Primary outcome measureBlood metabolic health markers (glucose and lipid parameters) will be measured at baseline and 8 weeks using standard enzymatic and immunoturbidimetric assays.
Secondary outcome measures1. Menopausal symptoms measured using the Kupperman Index and Pittsburgh Sleep Quality Index (PSQI) at baseline and 8 weeks
2. Hormone levels (estradiol [E2] and follicle-stimulating hormone [FSH]) measured using chemiluminescence microparticle immunoassay and electrochemiluminescence microparticle immunoassay at baseline and 8 weeks
3. Continuous glucose monitoring (CGM) measured using iPro2 (Medtronic Diabetes, Northridge, CA, USA) at baseline and 8 weeks
4. Plasma and urine metabolomics measured using GC-TOF-MS at baseline and 8 weeks
5. Nutritional intake measured using mobile application during 8 weeks intervention period
Overall study start date30/01/2019
Completion date17/09/2021

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit50 Years
Upper age limit65 Years
SexFemale
Target number of participants60
Total final enrolment65
Key inclusion criteria1. Women aged >50 and <65 years
2. Subjects with a low intake level of at least one of the target nutrients, below the Korean dietary recommendations (75 mg isoflavones, 2.0 g omega-3 fatty acids, 18.8 g dietary fiber, and 600 mg calcium), as assessed by a 3-day dietary survey (2 weekdays and 1 weekend day)
Key exclusion criteria1. Subjects with hypersensitivity to specific foods or ingredients
2. Subjects with difficulty using smartphones
Date of first enrolment07/06/2021
Date of final enrolment01/07/2021

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Ewha Clinical Trial Center, Ewha Womans University Mokdong Hospital
1071 Anyangcheon-ro, Yangcheon-gu
Seoul
07985
Korea, South

Sponsor information

Funders

Funder type

University/education

Ewha Womans University
Private sector organisation / Universities (academic only)
Alternative name(s)
Ewha
Location
Korea, South
Dr. Kitchen Co., Ltd

No information available

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a peer-reviewed journal.
IPD sharing planThe datasets are not expected to be made available because participant consent and IRB approval did not cover public data sharing.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 15/10/2025 No Yes

Additional files

48172 Participant information sheet.pdf

Editorial Notes

15/10/2025: Trial's existence confirmed by Ewha Womans University Mokdong Hospital.